Francisco Ayala de la Peña

20PUBLICATIONS
84CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markersTransgender studiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Feb 02, 2026
Is mortality truly higher for oncology patients admitted to intensive care units? A matched cohort observational study.

Marta Zafra Poves, Maria Angeles Vicente Conesa, Maria Esperanza Guirao García

|Nov 29, 2025
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025).

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori

|Jul 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Jul 07, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Jun 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

|Apr 18, 2025
Oncological needs in transgender patients.

Francisco Ayala de la Peña, David Martínez-Ramos, Oscar Juan-Vidal

Pageof 4

Frequent Collaborators

3 joint publications

Alexander Kirchmair

3 joint publications

Zlatko Trajanoski

3 joint publications

Esther Navarro-Manzano

3 joint publications

Fernando Henao Carrasco